UPDATE 3-AbbVie to buy Botox-maker Allergan in $63 bln deal
June 25, 2019 at 07:30 AM EDT
Drugmaker AbbVie Inc said on Tuesday it would buy Botox-maker Allergan Plc for about $63 billion, grabbing control of by far the biggest name in medical aesthetics to help reduce its reliance on blockbuster arthritis treatment Humira.
